144 related articles for article (PubMed ID: 19539583)
1. Co-administration of cholera toxin and apple polyphenol extract as a novel and safe mucosal adjuvant strategy.
Yoshino N; Fujihashi K; Hagiwara Y; Kanno H; Takahashi K; Kobayashi R; Inaba N; Noda M; Sato S
Vaccine; 2009 Jul; 27(35):4808-17. PubMed ID: 19539583
[TBL] [Abstract][Full Text] [Related]
2. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice.
Huang CF; Wu TC; Chu YH; Hwang KS; Wang CC; Peng HJ
Scand J Immunol; 2008 Nov; 68(5):502-10. PubMed ID: 18822109
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of ovalbumin-specific IgA responses via oral boosting with antigen co-administered with an aqueous Solanum torvum extract.
Israf DA; Lajis NH; Somchit MN; Sulaiman MR
Life Sci; 2004 Jun; 75(4):397-406. PubMed ID: 15147827
[TBL] [Abstract][Full Text] [Related]
4. Nasally administered cholera toxin A-subunit acts as a mucosal adjuvant.
Campos EA; Namikoshi J; Maeba S; Yamamoto M; Fukumoto M; Yamamoto H
J Oral Sci; 2003 Mar; 45(1):25-31. PubMed ID: 12816361
[TBL] [Abstract][Full Text] [Related]
5. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines.
Armstrong ME; Lavelle EC; Loscher CE; Lynch MA; Mills KH
J Infect Dis; 2005 Nov; 192(9):1628-33. PubMed ID: 16206078
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo effects of apple peel polyphenols against Helicobacter pylori.
Pastene E; Speisky H; García A; Moreno J; Troncoso M; Figueroa G
J Agric Food Chem; 2010 Jun; 58(12):7172-9. PubMed ID: 20486708
[TBL] [Abstract][Full Text] [Related]
8. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice.
Cuburu N; Kweon MN; Song JH; Hervouet C; Luci C; Sun JB; Hofman P; Holmgren J; Anjuère F; Czerkinsky C
Vaccine; 2007 Dec; 25(51):8598-610. PubMed ID: 17996991
[TBL] [Abstract][Full Text] [Related]
10. The mucosal adjuvanticity of the oligodeoxynucleotides containing a non-methylated CpG motif on BCG and diphtheria toxoid.
Maeyama J; Komiya T; Takahashi M; Isaka M; Goto N; Yamamoto S
Vaccine; 2009 Feb; 27(8):1166-73. PubMed ID: 19136040
[TBL] [Abstract][Full Text] [Related]
11. Polyphenol-enriched apple extract attenuates food allergy in mice.
Zuercher AW; Holvoet S; Weiss M; Mercenier A
Clin Exp Allergy; 2010 Jun; 40(6):942-50. PubMed ID: 20175787
[TBL] [Abstract][Full Text] [Related]
12. The use of a mutant TNF-alpha as a vaccine adjuvant for the induction of mucosal immune responses.
Kayamuro H; Abe Y; Yoshioka Y; Katayama K; Nomura T; Yoshida T; Yamashita K; Yoshikawa T; Kawai Y; Mayumi T; Hiroi T; Itoh N; Nagano K; Kamada H; Tsunoda S; Tsutsumi Y
Biomaterials; 2009 Oct; 30(29):5869-76. PubMed ID: 19646748
[TBL] [Abstract][Full Text] [Related]
13. The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action.
Grdic D; Smith R; Donachie A; Kjerrulf M; Hörnquist E; Mowat A; Lycke N
Eur J Immunol; 1999 Jun; 29(6):1774-84. PubMed ID: 10382739
[TBL] [Abstract][Full Text] [Related]
14. A two-codon mutant of cholera toxin lacking ADP-ribosylating activity functions as an effective adjuvant for eliciting mucosal and systemic cellular immune responses to peptide antigens.
Lomada D; Gambhira R; Nehete PN; Guhad FA; Chopra AK; Peterson JW; Sastry KJ
Vaccine; 2004 Dec; 23(4):555-65. PubMed ID: 15530705
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction between cholera toxin and dendritic cells is required for oral adjuvant activity.
Gustafsson T; Hua YJ; Dahlgren MW; Livingston M; Johansson-Lindbom B; Yrlid U
Eur J Immunol; 2013 Jul; 43(7):1779-88. PubMed ID: 23649516
[TBL] [Abstract][Full Text] [Related]
16. Cholera toxin as a mucosal adjuvant. Glutaraldehyde treatment dissociates adjuvanticity from toxicity.
Liang XP; Lamm ME; Nedrud JG
J Immunol; 1989 Jul; 143(2):484-90. PubMed ID: 2544646
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant effect of cholera toxin on the mucosal immune response to soluble proteins. Differences between mouse strains and protein antigens.
Wilson AD; Stokes CR; Bourne FJ
Scand J Immunol; 1989 Jun; 29(6):739-45. PubMed ID: 2740843
[TBL] [Abstract][Full Text] [Related]
18. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
[TBL] [Abstract][Full Text] [Related]
19. A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants.
Fujihashi K; Koga T; van Ginkel FW; Hagiwara Y; McGhee JR
Vaccine; 2002 Jun; 20(19-20):2431-8. PubMed ID: 12057597
[TBL] [Abstract][Full Text] [Related]
20. CD11c(high )dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization.
Fahlén-Yrlid L; Gustafsson T; Westlund J; Holmberg A; Strömbeck A; Blomquist M; MacPherson GG; Holmgren J; Yrlid U
J Immunol; 2009 Oct; 183(8):5032-41. PubMed ID: 19786541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
